Corthera

About:

Corthera is engaged in acquiring, developing and commercializing therapies for illnesses in the acute care setting.

Top Investors: Kleiner Perkins, Domain Associates, Johnson & Johnson Development Corporation, Caxton Advantage Life Sciences Fund

Description:

Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.

Total Funding Amount:

$40.1M

Headquarters Location:

San Carlos, California, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)corthera.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2007-12-20

IPO Status:

Private

Industries: